SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028753
Filing Date
2022-08-09
Accepted
2022-08-09 16:09:34
Documents
109
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-10q_20220630.htm   iXBRL 10-Q 3895863
2 EX-31.1 mnkd-ex311_9.htm EX-31.1 17419
3 EX-31.2 mnkd-ex312_6.htm EX-31.2 17397
4 EX-32.1 mnkd-ex321_10.htm EX-32.1 7314
5 EX-32.2 mnkd-ex322_7.htm EX-32.2 7303
  Complete submission text file 0001564590-22-028753.txt   15919645

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20220630.xsd EX-101.SCH 112074
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20220630_cal.xml EX-101.CAL 87815
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20220630_def.xml EX-101.DEF 453757
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20220630_lab.xml EX-101.LAB 705815
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20220630_pre.xml EX-101.PRE 649122
103 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-10q_20220630_htm.xml XML 3346145
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 221148349
SIC: 2834 Pharmaceutical Preparations